Navigation Links
Surface Logix Announces Executive Management Changes
Date:5/15/2008

BOSTON, May 15 /PRNewswire/ -- Surface Logix today announced that Jim Mahoney, President & CEO, will be stepping down from his current position to pursue other interests. Mr. Mahoney will maintain a consulting relationship with the company for the foreseeable future. Steven Gillis, Ph.D., Managing Director at ARCH Venture Partners will assume the role of Executive Chairman until a new CEO is appointed.

"The Board, shareholders and employees of Surface Logix would like to thank Jim for his considerable contributions to the Company. He led the transformation of Surface Logix from a chemistry platform to a small molecule drug discovery and development company with two internally generated programs having completed several successful Phase 2a clinical trials. Everyone at Surface Logix wishes Jim well in his decision to pursue other interests," said Steven Gillis. "Surface Logix is well positioned to move forward both of our cardiovascular programs, SLx-4090 and SLx-2101, into Phase 2b studies. Both programs have demonstrated clear efficacy and excellent tolerability and safety in clinical trials to date. We will also continue our research activities aimed at bringing exciting new programs to the clinic."

About Surface Logix, Inc.

Surface Logix, Inc. uses its expertise in biophysical chemistry to create and develop novel small molecule drugs (NCEs) with superior drug-like properties that are clearly differentiated from competitive products. The company is advancing multiple internal programs focused primarily on cardiovascular, metabolic, oncologic and fibrotic diseases. For more information, please visit http://www.surfacelogix.com .

Contact:

Leland Webster, Ph.D., M.B.A.

Surface Logix, Inc.

Vice President, Corporate Development

617.746.8520

Media:

Kari Watson

MacDougall Biomedical Communications Inc.

kwatson@macbiocom.com

781-235-3060


'/>"/>
SOURCE Surface Logix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Surface dislocation nucleation: Strength is but skin deep at the nanoscale, Penn engineers discover
2. CaviWipes(R): Taking Surface Disinfection to a New Level
3. Arthrosurface Raises $4 Million of Preferred Equity Financing
4. Harland Medical Systems to Offer March Plasma Systems Surface Materials
5. Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
6. Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry
7. Sureshield Coatings Company Established to Market Industry-Leading Portfolio of Advanced Coatings for Metal Surfaces
8. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
9. Physicists pin down spin of surface atoms
10. /C O R R E C T I O N from Source -- Resverlogix Corp./
11. Resverlogix Notice of Conference Call & Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... DES MOINES, Iowa , Feb. 22, 2017 Origin ... an agricultural biotechnology trait and seed provider, and Arcadia ... -based company that develops and commercializes agricultural productivity traits and ... of a key corn biotechnology product developed in China ... completion of global regulatory trials. ...
(Date:2/22/2017)... and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 /PRNewswire/ ... today announced its financial results for the fourth ... "Our annual 2016 financial results reflect continued growth ... exceeded $700 million," said Martine Rothblatt, Ph.D., United ... results strengthen our ability to develop and advance ...
(Date:2/21/2017)... ... February 21, 2017 , ... Genedata, ... development (R&D), today announced the establishment of Genedata Limited as a new subsidiary ... a recognized expert in life science informatics. Creating the UK subsidiary reinforces Genedata’s ...
(Date:2/21/2017)... ... 2017 , ... Creation Technologies, a private company and 25-year ... (OEMs) , today announced it has received the ‘Highest Overall Customer Rating’ Service ... category of electronics manufacturing services (EMS) providers with annual revenues over $500 million. ...
Breaking Biology Technology:
(Date:2/8/2017)... YORK , Feb. 8, 2017 About ... individual,s voice to match it against a stored ... such as pitch, cadence, and tone are compared ... require minimal hardware installation, as most PCs already ... for different transactions. Voice recognition biometrics are most ...
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
Breaking Biology News(10 mins):